Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Editorial: Angiogenesis agents

Cezary Marcinkiewicz

    Current Pharmaceutical Design
    |January 29, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    RETRACTED: Naamneh et al. Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. <i>Pharmaceuticals</i> 2024, <i>17</i>, 549.

    Pharmaceuticals (Basel, Switzerland)·2025
    Same author

    RETRACTED: Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities.

    Pharmaceuticals (Basel, Switzerland)·2024
    Same author

    Effect of Dimeric Disintegrins Isolated from <i>Vipera lebetina obtusa</i> Venom on Glioblastoma Cellular Responses.

    Cancers·2023
    Same author

    Integrin α<sub>2</sub>β<sub>1</sub>-Targeted Self-Assembled Nanocarriers for Tumor Bioimaging.

    ACS applied bio materials·2022
    Same author

    Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis.

    JACS Au·2022
    Same author

    Pharmacodynamic Studies of Fluorescent Diamond Carriers of Doxorubicin in Liver Cancer Cells and Colorectal Cancer Organoids.

    Nanotechnology, science and applications·2021
    Same journal

    Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

    Current pharmaceutical design·2026
    Same journal

    Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

    Current pharmaceutical design·2026
    Same journal

    Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

    Current pharmaceutical design·2026
    Same journal

    Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

    Current pharmaceutical design·2026
    Same journal

    Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

    Current pharmaceutical design·2026
    Same journal

    Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

    Current pharmaceutical design·2026
    See all related articles